Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP) Peptide

CNP Reactivity: Human Host: Synthetic BP, WB, IP
Catalog No. ABIN975133

Quick Overview for 2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP) Peptide (ABIN975133)

Target

Cnpase (CNP) (2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP))

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB), Immunoprecipitation (IP)
  • Characteristics

    This is a synthetic peptide designed for use in combination with anti-CNP antibody (Catalog #: ARP33880_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Cnpase (CNP) (2',3'-Cyclic Nucleotide 3' phosphodiesterase (CNP))

    Background

    2',3'-Cyclic nucleotide-3'-phosphodiesterase (CNP1 and CNP2) is the major enzyme of central nervous system myelin. It is associated with oligodendroglial plasma membrane and uncompacted myelin (myelin-like fraction), which are in contact with glial cytoplasm

    Alias Symbols: CNP1

    Protein Interaction Partner: MTNR1A,PRKCD,TUBA1A

    Protein Size: 401

    Molecular Weight

    45 kDa

    Gene ID

    1267

    NCBI Accession

    NM_033133, NP_149124
You are here:
Chat with us!